Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (166)

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

  2. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

  3. B-lymphocyte hyperactivation and autoantibody production in the pathophysiology of cutaneous systemic sclerosis

    Revista Colombiana de Reumatologia

  4. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)

    Lupus, Vol. 29, Núm. 1, pp. 27-36

  5. Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry

    Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 110-115

  6. Influence of MUC5B gene on antisynthetase syndrome

    Scientific Reports, Vol. 10, Núm. 1

  7. Insights into the procoagulant profile of patients with systemic lupus erythematosus without antiphospholipid antibodies

    Journal of Clinical Medicine, Vol. 9, Núm. 10, pp. 1-17

  8. Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: A preliminary report

    Rheumatology (United Kingdom), Vol. 59, Núm. 7, pp. 1671-1678

  9. Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome

    Rheumatology International, Vol. 40, Núm. 8, pp. 1259-1265

  10. Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment

    Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 71-86

  11. Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part II: Obstetric Antiphospholipid Syndrome and Special Situations

    Reumatologia Clinica, Vol. 16, Núm. 2P2, pp. 133-148